FDA Approves Tralokinumab for Treating Eczema in Adolescents FDA Approves Tralokinumab for Treating Eczema in Adolescents

It is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis that specifically targets the interleukin (IL)-13 cytokine.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Source Type: news